48 C.F.R. §§ 27.204-1
Current through November 30, 2024
When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals.
48 C.F.R. §§27.204-1